BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20954279)

  • 1. HBx-induced reactive oxygen species activates hepatocellular carcinogenesis via dysregulation of PTEN/Akt pathway.
    Ha HL; Yu DY
    World J Gastroenterol; 2010 Oct; 16(39):4932-7. PubMed ID: 20954279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus X protein increases microRNA‑21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog/phosphoinositide 3‑kinase/protein kinase B signaling pathway.
    Hou Z; Quan J
    Mol Med Rep; 2017 May; 15(5):3285-3291. PubMed ID: 28339072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model.
    Kong G; Zhang J; Zhang S; Shan C; Ye L; Zhang X
    PLoS One; 2011 May; 6(5):e19518. PubMed ID: 21573166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN).
    Damania P; Sen B; Dar SB; Kumar S; Kumari A; Gupta E; Sarin SK; Venugopal SK
    PLoS One; 2014; 9(3):e91745. PubMed ID: 24633222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.
    He B; Peng F; Li W; Jiang Y
    J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation.
    Niu LJ; Huang T; Wang L; Sun XF; Zhang YM
    Ann Hepatol; 2022; 27(3):100688. PubMed ID: 35196550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis B virus X protein suppresses adriamycin-induced apoptosis of hepatocellular carcinoma cells and expression of p53 and PTEN].
    Wang X; Yang L; She JJ; Fan HM; Zhang FC; Chen YM; Xie QF
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1775-8. PubMed ID: 20813662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of ERK and AKT pathways by hepatitis B virus X protein via the Notch1 pathway in hepatocellular carcinoma.
    Liao B; Zhou H; Liang H; Li C
    Int J Oncol; 2017 Nov; 51(5):1449-1459. PubMed ID: 29048612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells.
    Chung TW; Lee YC; Ko JH; Kim CH
    Cancer Res; 2003 Jul; 63(13):3453-8. PubMed ID: 12839924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway.
    Zhou Y; Zhang M; Zhang Z; Jia Y; Zhang C; Peng L
    Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
    Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
    Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway.
    Feng X; Jiang J; Shi S; Xie H; Zhou L; Zheng S
    Int J Oncol; 2016 Dec; 49(6):2600-2610. PubMed ID: 27840896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN modulates hepatitis B virus-X protein induced survival signaling in Chang liver cells.
    Kang-Park S; Im JH; Lee JH; Lee YI
    Virus Res; 2006 Dec; 122(1-2):53-60. PubMed ID: 16872708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic circuit constituted by Ser31-HBx and Akt increases risks of chronic hepatitis and hepatocellular carcinoma.
    Lee WP; Lan KH; Li CP; Chao Y; Lin HC; Lee SD
    Biochim Biophys Acta; 2016 Apr; 1862(4):837-849. PubMed ID: 26791804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover.
    Chi HC; Chen SL; Lin SL; Tsai CY; Chuang WY; Lin YH; Huang YH; Tsai MM; Yeh CT; Lin KH
    Oncogene; 2017 Sep; 36(37):5274-5284. PubMed ID: 28504722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X induces cell proliferation in the hepatocarcinogenesis via up-regulation of cytoplasmic p21 expression.
    Yano M; Ohkoshi S; Aoki YH; Takahashi H; Kurita S; Yamazaki K; Suzuki K; Yamagiwa S; Sanpei A; Fujimaki S; Wakai T; Kudo SE; Matsuda Y; Aoyagi Y
    Liver Int; 2013 Sep; 33(8):1218-29. PubMed ID: 23590292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
    Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X
    Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus x protein accelerated the proliferation of hepatocellular carcinoma cell through lncRNA SNHG20/PTEN pathway.
    Tu W; Yang Y; Song Y; Zhu W
    J Biochem; 2019 May; 165(5):423-431. PubMed ID: 30690477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.